1 / 6

Bioreactors Market Size, Trends, Share Report, 2024 | Hexa Research

worldwide bioreactors market is projected over USD 550 million by 2024, growing at a CAGR above 18% during the forecast period (2016-2024).

Carrol
Télécharger la présentation

Bioreactors Market Size, Trends, Share Report, 2024 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Bioreactors Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research “Worldwide Bioreactors market is projected over USD 550 million by 2024, growing at a CAGR above 18% during the forecast period (2016-2024).” The worldwide Bioreactors Market is anticipated to generate revenues over USD 550 million by 2024. It will grow at a CAGR above 18% in the forecast period (2016-2024). The industry is driven by the demand for biologics and adoption of single-use bioreactors (SUBs) & hybrid bioreactors. Rising popularity of SUBs in pharmaceutical manufacturing companies is yet another key driver. SUBs or disposable bioreactors contain disposable bags instead of cultural vessels. They face high demand from the medical sector. These reactors are adopted by pharmaceutical companies to manufacture drugs without any negotiations on their quality. These systems differ in view of flexibility and cultural medium. Commercial bioreactors include CellMarket Regular from Cellexus and HyClone SUB from Thermo Fisher Scientific. Browse Details of Report@ https://www.hexaresearch.com/research-report/bioreactors-market Follow Us:

  2. Your Catalyst To a Lucrative Business Low functional costs of SUBs and low maintenance required for them can propel market demand from 2016 to 2024. Moreover, convenience associated with marine-microbe culturing coupled with low energy consumption by SUBs could favor these reactors. But low volume capacities of SUBs can hamper the industry. The worldwide Bioreactors Market is fragmented on the basis of products, cells, molecules, technologies, end-users, and regions. Products include monoclonal antibodies and recombinant proteins. Monoclonal antibodies are projected to reign owing to their efficiency in medical treatments. Yeast, bacteria, and mammalian cells are the various cells. Mammalian cells should be the most rapidly growing segment. This will be attributed to their high bio-molecular effectiveness. Recombinant proteins, monoclonal antibodies (MAbs), gene therapy, stem cells, and vaccines are classified under molecules. MAbs are used by biologics industry to manufacture vaccines. This may augments the demand for bioreactors in the next eight years. Low investment costs of SUBs to make MAbs on a small scale can add to overall market demand. Single use bubble column bioreactor, stirred SUBs, and wave-induced motion SUBs constitute the technologies. Wave-induced motion SUBs are likely to notice the highest growth rate till 2024. Surging growth can be attributed to their high flexibility and short lead times. End-users in the Bioreactors Market comprise R&D departments and biopharmaceutical manufacturers. The former are sub-divided into biopharmaceutical companies, contract research organizations (CROs), and research institutes. Regions are Asia Pacific, North America, Europe, and RoW (Rest of the World). North America & Europe would garner major shares by 2024. This will be ascribed to their key biopharmaceutical firms. Europe is predicted to capture large shares due to biologic drug patents reaching expiry. Also, regional assistance for biologic manufacturers to produce drugs with high effectiveness should benefit the region. Asia Pacific is likely to display significant expansion because of investment opportunities for its major biologic manufacturers. Key firms opening their manufacturing units in Latin America will benefit the region. Key companies in the global Bioreactors Market are GE Healthcare, Thermo Fisher Scientific Inc., Merck KGaA, and Sartorius Stedim Biotech S.A. They are expected to further their product portfolio and offer system flexibility. Follow Us:

  3. Your Catalyst To a Lucrative Business This could make consumer segments well-acquainted with various blends of bioprocessing components. It can also help them with buying decisions. Product endorsements via commercial manufacturing to obtain the finest application solutions may augur well for the market. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry Follow Us:

  4. Your Catalyst To a Lucrative Business Table of Content of Bioreactors Market 1. Methodology & Scope 1.1 Research Methodology 1.1.1 Initial Data Exploration 1.1.2 Statistical Modeling and Forecast 1.1.3 Industry Insights and Validation 1.2 Research Scope & Assumptions 1.3 List of Data Sources 2. Executive Summary 2.1 Industry Summary of Bioreactors Market 3. Industry Outlook 3.1 Bioreactors Market Segmentation 3.2 Bioreactors Market Size and Growth Prospects 3.3 Bioreactors Market Dynamics 3.4 Key Opportunities Prioritized 3.5 Industry Analysis - Porter's 3.6 Market Share Analysis 3.7 Market PESTEL Analysis, 2016 4. Application Framework 4.1 Bioreactors Market share by application, 2016 & 2024 5. Regional Outlook 5.1 North America 5.2 Europe 5.3 Asia Pacific 5.4 Latin America 5.5 MEA (Middle East and Africa) 5.6 RoW (Rest of the World) 6. Competitive Landscape 6.1 GE Healthcare Follow Us:

  5. Your Catalyst To a Lucrative Business 6.1.1 Company Overview 6.1.2 Revenue Analysis 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 Thermo Fisher Scientific Inc. 6.2.1 Company Overview 6.2.2 Revenue Analysis 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 Merck KGaA 6.3.1 Company Overview 6.3.2 Revenue Analysis 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 Sartorius Stedim Biotech S.A. 6.4.1 Company Overview 6.4.2 Revenue Analysis 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives Follow Us:

  6. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us:

More Related